Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 2, 2013

View Archived Issues

Lacer prepares new strontium salts for osteoporosis

New autotaxin inhibitors claimed by Bristol-Myers Squibb

Progen Pharmaceuticals signs license term sheet for PG-545

Special protocol assessment agreement reached for phase III AEZS-108 trial

Synergy Pharmaceuticals' GC-C agonist SP-333 completes phase I trial

Emergent BioSolutions acquires rights to pandemic influenza vaccine candidate

Phase IIb trial begins for plecanatide in IBS-C

Proteome Sciences' CKI-delta inhibitors improve cognition in Alzheimer's disease model

Targeting MALT1 as a therapeutic approach for ABC-DLBCL

AI-10-49 proves effective in murine leukemia model

In vivo profiling of mGlu5 receptor modulators

Hutchison MediPharma presents novel SYK inhibitors

Swiss researchers present new antibacterial prodrugs

New beta-amyloid ligands disclosed by Italian researchers

CT Atlantic and the Universitat Zurich patent novel antibodies for cancer

Affectis Pharmaceuticals synthesizes novel P2X7 receptor antagonists

New compound demonstrates efficacy in KSHV-associated primary effusion lymphoma

New hydrid cholinesterase inhibitors divulged by Polish team

Chugai Pharmaceutical develops novel bispecific antibody for hemophilia

Xoma to study gevokizumab for noninfectious anterior scleritis

FDA grants accelerated approval for Sirturo in tuberculosis

Data presented from phase Ib trial of a ghrelin receptor agonist for type 2 diabetes

Evotec and Apeiron Biologics establish cancer immunotherapy collaboration

Third milestone in Vernalis' drug discovery collaboration with Lundbeck

FDA approves Fulyzaq for diarrhea in patients with HIV/AIDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...